Trial designed with a two-week run-in period to reduce the well-known placebo effect in trials involving pain componentTop-line data from trial anticipated in Q4, 2023 LONDON and NEW YORK,…
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of…
A recent study in the Journal of Biological Chemistry revealed the key to a protein that commonly causes blindness. The biological process involves a protein that is essential for…
IANS
San Francisco, February 17
A team of researchers found that the coronavirus that causes Covid-19 can be detected in tears sampled by ocular swabs, a new study has shown.
The…